Peters, Michael
June 2004
BMA A-Z Family Medical Encyclopedia;2004, p759
Reference Entry
A definition of the term "triamterene" is presented. The term refers to a type of diuretic drug. Among the conditions treated by triamterene are hypertension or high blood pressure and oedema or accumulation of fluid in tissue. Nausea, vomiting and weakness are some of the possible side effects of administering the drug.


Related Articles

  • Peripheral Edema Related to Paroxetine Discontinuation: A Case Report. Mermi, Osman; Atmaca, Murad // Klinik Psikofarmakoloji Bulteni;2015, Vol. 25 Issue 3, p291 

    Paroxetine is a selective serotonin reuptake inhibitor (SSRI), with antidepressant and anxiolytic characteristics. In association with paroxetine cessation, certain side effects can be observed frequently, including dizziness, vertigo, nausea, vomiting, headache, anxiety, insomnia, and...

  • pentazocine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p596 

    A definition of the term "pentazocine" is presented. It refers to an opioid analgesic drug used to relieve moderate or severe pain caused by injury, surgery, cancer or childbirth. Pentazocine is seldom used because of its possible side effects, which include dizziness, drowsiness, nausea,...

  • cyclopenthiazide. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p208 

    A definition of the term "cyclopenthiazide" is presented. It refers to a thiazide diuretic drug used to reduce oedema associated with heart failure, kidney disorders, cirrhosis of the liver and to treat hypertension. Side effects of cyclopenthiazide include lethargy, loss of appetite, leg...

  • Benefits and Risks of Newer Treatments for Chemotherapy-Induced and Postoperative Nausea and Vomiting. Kovac, Anthony L. // Drug Safety;Feb2003, Vol. 26 Issue 4, p227 

    Nausea and vomiting are common adverse effects of chemotherapy, radiation therapy, anaesthesia and surgery. The incidence of chemotherapy-induced nausea and vomiting (CINV) is estimated to vary from 30 to 90%, depending on the type of chemotherapeutic agent used. Radiation-induced emesis varies...

  • Fluoxetine/hydrochlorothiazide.  // Reactions Weekly;11/7/2009, Issue 1277, p22 

    The article describes two cases of hypnotraemia during hydrochlorothiazide or fluoxetine therapy. The first patient was a 31-year-old woman with hypertension who experienced nausea for six weeks post-partum. After taking hydrochlorothiazide, she experienced nausea, vomiting and orthostatic...

  • Insulin glargine.  // Reactions Weekly;3/19/2005, Issue 1043, p14 

    Discusses a case report of a 34-year-old woman who experienced nausea and vomiting during treatment with insulin glargine for type 1 diabetes mellitus. Reference to a study by A. A. Dixon et al, published in the February 26, 2005 issue of the "British Medical Journal"; Drug replaced for...

  • Dexamethasone.  // Reactions Weekly;4/5/2008, Issue 1196, p14 

    The article describes the case of a child who developed tumour lysis syndrome after taking dexamethasone for postoperative nausea and vomiting. The patient underwent a procedure to implant a central venous port catheter before receiving treatment with antineoplastics. The author says the...

  • Patient outcomes after therapeutic interchange of dolasetron for granisetron. Steiner, MaryAnn; Yorgasan, Rossana Zolessi; Vermeulen, Lee C.; Theisen, Joseph // American Journal of Health-System Pharmacy;5/15/2003, Vol. 60 Issue 10, p1023 

    Evaluates the impact of using therapeutic interchange of dolasetron for granisetron for the prevention of chemotherapy-induced nausea and vomiting. Comparison of changes in functional status before and after treatment; Examination of nausea and vomiting frequency, satisfaction with antiemetics...

  • Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis. Herrstedt, J.; Roila, F. // Annals of Oncology;May2008 Supplement 2, Vol. 19 Issue 0, pii110 

    The article presents the clinical recommendations of the European Society for Medical Oncology (ESMO) for the use of prophylaxis in chemotherapy-induced nausea and vomiting. It considers other causes of nausea and vomiting include radiotherapy, radiosensitizers and cachexia syndrome, among...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics